Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer. [electronic resource]
Producer: 20120117Description: 6021-8 p. digitalISSN:- 1557-3265
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Renal Cell -- diagnostic imaging
- Female
- Fluorodeoxyglucose F18
- Humans
- Indoles -- therapeutic use
- Kaplan-Meier Estimate
- Kidney Neoplasms -- diagnostic imaging
- Male
- Middle Aged
- Multimodal Imaging
- Neoplasm Metastasis
- Positron-Emission Tomography
- Prognosis
- Pyrroles -- therapeutic use
- Sunitinib
- Tomography, X-Ray Computed
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.